BioCryst Pharmaceuticals reported 536 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
BioCryst Pharmaceuticals 536 5 Dec/2023
Chugai Pharma 7.78K 174 Dec/2024
Daiichi Sankyo 19.76K 1.04K Dec/2025
DBV Technologies USD 104 19 Dec/2023
Enanta Pharmaceuticals 145 15 Sep/2023
Gilead Sciences 17.6K 400 Dec/2024
GlaxoSmithKline 69.4K 20.7K Dec/2022
Glaxosmithkline GBP 69.4K 20.7K Dec/2022
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Karyopharm Therapeutics 325 60 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Novavax 1.54K 449 Dec/2023
PTC Therapeutics 939 49 Dec/2024
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Roche Holding 103.61K 2.69K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024